Table 3. Factors Associated With Risk for TOL-CD Among Kidney and Liver Transplant Recipients.
| Factor | TOL-CD, aOR (95% CI)a | |
|---|---|---|
| Kidney transplant (n = 976) | Liver transplant (n = 325) | |
| Placental abruption | 12.96 (2.85-59.07) | 2.29 (0.31-16.97) |
| Pregestational diabetes | 5.44 (2.54-11.68) | 2.39 (0.47-12.06) |
| Induction of labor | 2.98 (2.04-4.37) | 1.92 (0.94-3.92) |
| Black race | 1.49 (0.79-2.79) | 2.88 (1.06-7.85) |
| Obesity | 2.57 (1.51-4.34) | 3.83 (1.17-12.51) |
| Gestational diabetes | 1.95 (1.10-3.48) | 1.36 (0.32-5.83) |
| Aspirin use | 1.93 (1.12-3.34) | 0.82 (0.26-2.61) |
| Hypertensive disorder | 1.91 (1.28-2.85) | 1.34 (0.64-2.82) |
| Repeated transplant | 1.79 (1.16-2.77) | 2.63 (0.93-7.41) |
| Nulliparity | 1.68 (1.20-2.35) | 3.45 (1.77-6.72) |
| Ageb | 0.96 (0.93-0.99) | 1.04 (0.98-1.10) |
Abbreviations: aOR, adjusted odds ratio; TOL-CD, cesarean delivery after trial of labor.
a
The model was adjusted for race and ethnicity, location, year of delivery, multiple gestation, chronic hypertension, preterm labor, fetal malformations, in vitro fertilization, transplant-to-conception interval, anticoagulation, gestational age, and birth weight percentile.
b
Each additional year.